Objective: Ileal neobladders (INBs) are routinely created in patients following cystectomy for urothelial carcinoma (UC). Patients are screened by urinary cytology for tumor recurrence. However, the diagnosis of urothelial atypia remains a nonstandardized category in INB specimens and has never been studied before. Study Design: The cytopathology archives from the Johns Hopkins Hospital were searched over a period of 19 years for specimens from patients with INB and atypical urine cytology. Follow-up surgical pathology results and clinical data were reviewed. Results: A total of 620 urine specimens were identified from patients with INB, 77 of which (12.4%) were diagnosed as ‘atypical’. Of the 51 patients who were followed up, only 3 developed a concordant local recurrence (5.9% positive predictive value), defined as biopsy-proven recurrence within 1 year of atypical cytology. The recurrent patients had more diagnoses of ‘atypical cells suspicious for carcinoma’ than nonrecurrent patients (66 vs. 11.4%; p > 0.10). Conclusion: A diagnosis of urothelial atypia in patients with INB is made as frequently as in patients with native bladders but with a lower positive predictive value (5.9 vs. 12%) for subsequent histologic diagnosis of UC. This suggests that the diagnosis of urothelial atypia in INB may have less clinical significance than in native bladders.

Keywords:
Urine, Cytology, Bladder, Urothelial carcinoma
1.
Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V; Papanicolaou Society of Cytopathology: Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol 2004;30:24–30.
2.
Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger M: Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol 2009;132:785–793.
3.
Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM: The accuracy of urinary cytology in daily practice. Cancer 1999;87:118–128.
4.
Renshaw AA: Subclassifying atypical urine cytology specimens. Cancer 2000;90:222–229.
5.
Haufman RE: Urinary diversion: ileal conduit to neobladder. J Urol 2003;169:834–842.
6.
Wolinska WH, Melamed MR: Urinary conduit cytology. Cancer 1973;32:1000–1006.
7.
Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG: Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 2005;173:1163–1168.
8.
Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP: Upper tract recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year follow up. J Urol 2007;177:2088–2094.
9.
Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM: Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol 2008;179:96–100.
10.
Tetu B: Diagnosis of urothelial carcinoma from urine. Mod Pathol 2009;22:S53–S59.
11.
Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G: Natural history of positive urinary cytology after radical cystectomy. J Urol 2006;176:2000–2005.
12.
Raab SS, Grzybicki DM, Vribin CM, Geisinger KR: Urine cytology discrepancies: frequency, causes and outcomes. Am J Clin Pathol 2007;127:946–953.
13.
Kapur U, Venkataraman G, Wojcik EM: Diagnostic significance of ‘atypia’ in instrumented versus voided urine specimens. Cancer 2008;114:270–274.
14.
Powsner SM, Costa J, Homer RJ: Clinicians are from Mars and pathologists are from Venus: clinical interpretation of pathology reports. Arch Pathol Lab Med 2000;124:1040–1046.
15.
Sternberg I, Rona R, Olsfanger S, Lew S, Leibovitch I: The clinical significance of class III (suspicious) urine cytology. Cytopathology 2010, E-pub ahead of print.
16.
Deshpande V, McKee GT: Analysis of atypical urine cytology in a tertiary care center. Cancer 2005;105:468–475.
17.
Mokhtar GA, Al-Dousari M, Al-Ghamedi D: Diagnostic significance of atypical category in the voided urine samples: a retrospective study in a tertiary care center. Urol Ann 2010;2:100–106.
18.
Yoshimine S, Kikuchi E, Matsumoto K, Ide H, Miyajima A, Nakagawa K, Oya M: The clinical significance of urine cytology after a radical cystectomy for urothelial cancer. Int J Urol 2010;17:527–532.
19.
Bhatia A, Dey P, Kakkar N, Srinivasan R, Nijhawan R: Malignant atypical cell in urine cytology: a diagnostic dilemma. Cytojournal 2006;3:28.
20.
Beyer-Boon ME, de Voogt HJ, van der Velde EA, Brussee JA, Schaberg A: The efficacy of urinary cytology in the detection of urothelial tumours: sensitivity and specificity of urinary cytology. Urol Res 1978;6:3–12.
21.
Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A: The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol 2005;31:304–308.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.